Approval · Notice of Compliance 9945 · 2008
DANTRIUM CAPSULES: Notice of Compliance 9945
Issued December 18, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9945
- Date
- December 18, 2008
- Company
- Jhp Pharmaceuticals Llc
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Skeletal muscle relaxant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DANTRIUM CAPSULES | 01997602 | Marketed |
| DANTRIUM CAPSULES | 01997653 | Cancelled Post Market |
Medicinal ingredients
- DANTROLENE SODIUM 25 MG per CAP
- DANTROLENE SODIUM 100 MG per CAP